Bellis Pharmaceuticals Limited

Bellis Pharmaceuticals Limited - chemicals in Bangalore, Karnataka, India. FY 2026 financials and compliance.
CIN U24232KA2009PLC051193 Incorporated 14 October 2009 ROC Bangalore HQ Bangalore, Karnataka, India
Struck Off Public Limited Company chemicals
Data last updated
Revenue · FY 2020
-
Latest filing
EBITDA · FY 2020
Locked
In full report
Net profit · FY 2020
Locked
In full report
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
17 yrs
Est. 2009
Last financials
Mar 2023
Balance sheet date

About Bellis Pharmaceuticals Limited

Data last updated: 23 July 2025

Bellis Pharmaceuticals Limited was a public limited company based in Bangalore, Karnataka, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It specialised in manufacturing, a part of the broader chemicals sector. Incorporated on 14 October 2009.

Registered with ROC Bangalore under CIN U24232KA2009PLC051193.

Capital: an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It was led by directors including Prakashchand Jain and Dhanraj Ostawal.

Last AGM: 31 July 2023. Financial statements filed for year ended 31 March 2023. Office: # 175/7 Bharat Complex A.S.Char Street, Bangalore, Karnataka, India – 560053.

The company is no longer operational and has been struck off from the Register of Companies, typically due to non-filing of annual returns or failure to commence business. Entering into any agreement with a struck-off entity carries significant legal and financial risk.

Company Details of Bellis Pharmaceuticals Limited
CIN U24232KA2009PLC051193
Registration Number 051193
Incorporation Date 14 October 2009
ROC Bangalore
Listing Status Unlisted
Company Status Struck Off
Date of Last AGM 31 July 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    # 175/7 Bharat Complex A.S.Char Street, Bangalore, Karnataka, India – 560053
  • Industry
    Chemicals, Manufacturing, Other Chemical Product
Company report
Bellis Pharmaceuticals Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Bellis Pharmaceuticals Limited report

Financials, compliance, directors, charges, ownership and filings for Bellis Pharmaceuticals Limited in one report.

10-year financials Directors & ownership Charges & compliance

Auditor Details of Bellis Pharmaceuticals Limited

Bellis Pharmaceuticals Limited is audited by R.H SETHIA ASSOCIATES for the financial year 2017. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
R.H SETHIA ASSOCIATES Locked Locked Locked
Premium access

Complete auditor history for Bellis Pharmaceuticals Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Bellis Pharmaceuticals Limited

Bellis Pharmaceuticals Limited is currently managed by 3 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Directors (as last reported)
Name Designation Appointment Date Tenure Status
Prakashchand Jain Director 21 Aug 2016 10 Years 0 Months As last reported
Dhanraj Ostawal Director 14 Oct 2009 16 Years 10 Months As last reported
Sunil Dhanraj Ostwal Director 14 Oct 2009 16 Years 10 Months As last reported

Financials of Bellis Pharmaceuticals Limited FY 2023 filings available

Premium access

Ten-year financial statements for Bellis Pharmaceuticals Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Bellis Pharmaceuticals Limited

Premium access

Shareholding and ownership data for Bellis Pharmaceuticals Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings Bellis Pharmaceuticals Limited

Bellis Pharmaceuticals Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Bellis Pharmaceuticals Limited

View historical data on people associated with Bellis Pharmaceuticals Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Bellis Pharmaceuticals Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Bellis Pharmaceuticals Limited

Premium access

GST registrations and filing compliance for Bellis Pharmaceuticals Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Bellis Pharmaceuticals Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Bellis Pharmaceuticals Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Bellis Pharmaceuticals Limited

Premium access

MSME payment history for Bellis Pharmaceuticals Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Bellis Pharmaceuticals Limited

Premium access

Corporate group structure for Bellis Pharmaceuticals Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Bellis Pharmaceuticals Limited

Premium access

MCA filings and documents for Bellis Pharmaceuticals Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Bellis Pharmaceuticals Limited

Activity
31 Jul 2023
Bellis Pharmaceuticals Limited last Annual general meeting of members was held on 31 Jul 2023 as per latest MCA records.
Activity
31 Mar 2023
Bellis Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.
Directors
21 Aug 2016
Prakashchand Jain was appointed as a Director on 21 Aug 2016 & has been associated with this company since 10 years 3 days.
Directors
14 Oct 2009
Dhanraj Ostawal was appointed as a Director on 14 Oct 2009 & has been associated with this company since 16 years 10 months.
Directors
14 Oct 2009
Sunil Dhanraj Ostwal was appointed as a Director on 14 Oct 2009 & has been associated with this company since 16 years 10 months.
Activity
14 Oct 2009
Bellis Pharmaceuticals Limited was registered on 14 Oct 2009 with Roc Bangalore & aged 16 years 10 months as per MCA records.

Frequently Asked Questions about Bellis Pharmaceuticals Limited

Bellis Pharmaceuticals Limited has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Bellis Pharmaceuticals Limited is a struck-off public limited company in the chemicals sector based in Bangalore, Karnataka, India. It was incorporated on 14 October 2009 and is registered under CIN U24232KA2009PLC051193. The company has been struck off by the Registrar of Companies and is no longer operational.

The current directors of Bellis Pharmaceuticals Limited are:

The CIN (Corporate Identification Number) of Bellis Pharmaceuticals Limited is U24232KA2009PLC051193. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The primary industry of Bellis Pharmaceuticals Limited is chemicals. The company specifically operates in manufacturing. The company was active in this sector before being struck off.

The company has its registered office at # 1757 Bharat Complex A.S.Char Street, Bangalore, Karnataka, India – 560053.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available